Roger S. McIntyre, MD: GLP-1 Agonists for Psychiatry? : comp

McIntyre explains why GLP-1/GIP receptor agonists like semaglutide may alter cognitive and psychiatric care similar to cardiometabolic disease.

Related Keywords

United States , New York , Toronto , Ontario , Canada , American , Rogers Mcintyre , , University Of Toronto , American Psychiatric Association , Apa , Aapa 2024 , Glp 1 , Agonists , Semaglutide , Retatrutide , Ozempic , Wegovy , Depression , Weight Loss , Alzheimer , Parkinson ,